|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
21,040,000 |
Market
Cap: |
1.03(B) |
Last
Volume: |
76,253 |
Avg
Vol: |
95,296 |
52
Week Range: |
$41.52 - $67.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile USANA Health Sciences develops and manufactures science-based nutritional, personal care and skincare products. Co.'s principal product lines include: USANA® Nutritionals Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs; Essentials/CellSentials®, which includes primary vitamin and mineral supplements that provide a foundation of body nutrition for every age group with children 13 months of age; Foods, which includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition in various formats; and Personal Care and Skincare, which includes its science-based personal care products and Celavive.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
36,990 |
48,445 |
65,028 |
143,144 |
Total Sell Value |
$1,763,385 |
$2,312,477 |
$3,371,359 |
$8,352,397 |
Total People Sold |
9 |
12 |
14 |
16 |
Total Sell Transactions |
10 |
15 |
26 |
50 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Noot Walter |
Chief Operating Officer |
|
2021-02-04 |
4 |
D |
$85.18 |
$62,267 |
D/D |
(731) |
2,336 |
|
- |
|
Noot Walter |
Chief Operating Officer |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,725 |
2,572 |
|
- |
|
Sinnott Robert A |
Chief Scientific Officer |
|
2021-02-04 |
4 |
D |
$85.18 |
$39,949 |
D/D |
(469) |
1,692 |
|
- |
|
Sinnott Robert A |
Chief Scientific Officer |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,044 |
1,921 |
|
- |
|
Guest Kevin |
C.E.O. |
|
2021-02-04 |
4 |
D |
$85.18 |
$144,125 |
D/D |
(1,692) |
5,931 |
|
- |
|
Guest Kevin |
C.E.O. |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,992 |
6,596 |
|
- |
|
Mulham David Mulham |
Chief Field Development Office |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,680 |
12,237 |
|
- |
|
Macuga Daniel A. |
Chief Communications Officer |
|
2021-02-04 |
4 |
D |
$85.18 |
$61,926 |
D/D |
(727) |
2,622 |
|
- |
|
Macuga Daniel A. |
Chief Communications Officer |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
2,857 |
|
- |
|
Brown Jim |
President |
|
2021-02-04 |
4 |
D |
$85.18 |
$105,964 |
D/D |
(1,244) |
4,164 |
|
- |
|
Brown Jim |
President |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,803 |
4,548 |
|
- |
|
Neidig Brent |
Chief Officer & MD of China |
|
2021-02-04 |
4 |
D |
$85.18 |
$29,387 |
D/D |
(345) |
1,497 |
|
- |
|
Neidig Brent |
Chief Officer & MD of China |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
777 |
1,618 |
|
- |
|
Foukas Joshua |
Chief Legal Officer |
|
2021-02-04 |
4 |
D |
$85.18 |
$61,500 |
D/D |
(722) |
2,242 |
|
- |
|
Foukas Joshua |
Chief Legal Officer |
|
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,703 |
2,475 |
|
- |
|
Iiekking G Doug |
CFO |
|
2021-02-03 |
4 |
D |
$82.76 |
$106,843 |
D/D |
(1,291) |
1,756 |
|
- |
|
Iiekking G Doug |
CFO |
|
2021-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,047 |
3,047 |
|
- |
|
Jones Paul A. |
Chief Leadership Dev Officer |
|
2021-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
956 |
6,362 |
|
- |
|
Noot Walter |
Chief Operating Officer |
|
2021-02-03 |
4 |
D |
$82.76 |
$81,684 |
D/D |
(987) |
1,342 |
|
- |
|
Noot Walter |
Chief Operating Officer |
|
2021-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,329 |
2,329 |
|
- |
|
Sinnott Robert A |
Chief Scientific Officer |
|
2021-02-03 |
4 |
D |
$82.76 |
$75,312 |
D/D |
(910) |
1,117 |
|
- |
|
Sinnott Robert A |
Chief Scientific Officer |
|
2021-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,027 |
2,027 |
|
- |
|
Guest Kevin |
C.E.O. |
|
2021-02-03 |
4 |
D |
$82.76 |
$164,361 |
D/D |
(1,986) |
3,631 |
|
- |
|
Guest Kevin |
C.E.O. |
|
2021-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,596 |
5,617 |
|
- |
|
Mulham David Mulham |
Chief Field Development Office |
|
2021-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,080 |
10,557 |
|
- |
|
2039 Records found
|
|
Page 22 of 82 |
|
|